Sabby Management, LLC Statera Biopharma, Inc. Transaction History

Sabby Management, LLC

  • $130,000
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.21 - $0.38 $14,511 - $26,259
-69,103 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.31 - $2.27 $97,803 - $716,171
-315,494 Reduced 82.03%
69,103 $22,000
Q4 2021

Feb 14, 2022
BUY
$2.01 - $4.08 $36,455 - $73,998
18,137 Added 4.95%
384,597 $885,000
Q3 2021

Nov 15, 2021
BUY
$2.29 - $6.24 $839,193 - $2.29 Million
366,460 New
366,460 $847,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email